SCHEMBL258995

SCHEMBL258995

N[C@H](C=O)CCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL68935 1.00
SCHEMBL859458 1.00
SCHEMBL15058114 0.98 CYP2D6 (0.61)
SCHEMBL7998715 0.98 CYP2D6 (0.61)
Hydrochloric Acid SCHEMBL10636409 0.98 CYP2D6 (0.61)
Hydrochloric Acid SCHEMBL31395319 0.98 CYP2D6 (0.61)
SCHEMBL28189436 0.98 CYP2D6 (0.61)
Aminolevulinic Acid SCHEMBL2446350 0.86 GABRR1 (0.59)
SCHEMBL12019170 0.86 ENPEP (0.52)
SCHEMBL11981919 0.84 ENPEP (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 294 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4448719-A1 A GENETIC FACTOR TO INCREASE EXPRESSION OF RECOMBINANT PROTEINS Impossible Foods Inc. (US) 2024-10-23 EP claimed
WO-2024216099-A1 SYSTEMS AND METHODS FOR BACTERIA-SPECIFIC PRO-PHOTOSENSITIZERS TO POTENTIATE BACTERICIDE THE GENERAL HOSPITAL CORPORATION (US) 2024-10-17 WO claimed
WO-2023114395-A1 A GENETIC FACTOR TO INCREASE EXPRESSION OF RECOMBINANT PROTEINS IMPOSSIBLE FOODS INC. (US) 2023-06-22 WO claimed
EP-0168832-B1 PHARMACEUTICAL COMPOSITION CONTAINING A TETRAPYRROLE COMPOUND AS ACTIVE INGREDIENT AND PROCESS FOR THE PRODUCTION OF THE TETRAPYRROLE COMPOUND Nippon Petrochemicals Co., Ltd. (JP) 1993-09-15 EP claimed
US-4675338-A PEPTIDE LINKAGES WITH ASPARTIC AND GLUTAMIC ACID; ANTITUMOR A GENTS NIPPON PETROCHEMICALS CO., LTD. (JP) 1987-06-23 US claimed
EP-0168832-A2 Pharmaceutical composition containing a tetrapyrrole compound as active ingredient and process for the production of the tetrapyrrole compound Nippon Petrochemicals Co., Ltd. (JP) 1986-01-22 EP claimed
JP-2021875-A None JP disclosed
JP-55051357-A None JP disclosed
WO-2026107392-A1 PSEUDOMONAS AERUGINOSA AGGREGATE GENES IN A CHRONIC INFECTION MODEL UNIVERSITY OF SOUTH FLORIDA (US) 2026-05-21 WO disclosed
US-20260125447-A1 FC VARIANTS WITH ALTERED BINDING TO NEONATAL FC RECEPTOR (FCRN) FOR VETERINARY USE ELANCO US INC (US) 2026-05-07 US disclosed
US-20260043008-A1 CELL CRYOPRESERVATIVE FORMULATIONS AND METHODS OF USE ASTELLAS INST FOR REGENERATIVE MEDICINE (US) 2026-02-12 US disclosed
EP-4687490-A1 ENZYME COMPOSITION AND BEER BREWING PROCESS DSM IP Assets B.V. (NL) 2026-02-11 EP disclosed
US-12496292-B2 PSMA binding ligand-linker conjugates and methods for using PURDUE RESEARCH FOUNDATION (US) 2025-12-16 US disclosed
EP-0629409-A1 Tetrapyrrole carboxylic acid derivatives for diagnosis and/or therapy of arthritis NIPPON PETROCHEMICALS CO., LTD. (JP) 1994-12-21 EP disclosed
US-5308861-A Tetrapyrole compounds NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) 1994-05-03 US disclosed
EP-0168832-B1 PHARMACEUTICAL COMPOSITION CONTAINING A TETRAPYRROLE COMPOUND AS ACTIVE INGREDIENT AND PROCESS FOR THE PRODUCTION OF THE TETRAPYRROLE COMPOUND Nippon Petrochemicals Co., Ltd. (JP) 1993-09-15 EP disclosed
US-4997639-A Porphyrins NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) 1991-03-05 US disclosed
JP-H0221875-A MEDICAL MATERIAL AND MEDICAL APPLIANCE TERUMO CORP 1990-01-24 JP disclosed
EP-0308983-A2 NMR imaging with Mn(II) coordination compositions SALUTAR, INC. (US) 1989-03-29 EP disclosed
JP-S5551357-A ARBOVIRUS AGGLUTINATION METHOD TAKEDA CHEM IND LTD 1980-04-15 JP disclosed